Switch to:
Medtronic Inc (NYSE:MDT)
Research and Development
$1,484 Mil (TTM As of Oct. 2014)

This is the expense the company spent on research and development. Medtronic Inc's research and development for the three months ended in Oct. 2014 was $374 Mil. Its research and development for the trailing twelve months (TTM) ended in Oct. 2014 was $1,484 Mil.


Definition

This is the expense the company spent on research and development.

Medtronic Inc Research & Development for the trailing twelve months (TTM) ended in Oct. 2014 was 360 (Jan. 2014 ) + 385 (Apr. 2014 ) + 365 (Jul. 2014 ) + 374 (Oct. 2014 ) = $1,484 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.


Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.


Related Terms

Gross Profit


Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

Medtronic Inc Annual Data

Apr05Apr06Apr07Apr08Apr09Apr10Apr11Apr12Apr13Apr14
Research & Development 9511,1131,2391,2751,3551,4601,5081,4901,5571,477

Medtronic Inc Quarterly Data

Jul12Oct12Jan13Apr13Jul13Oct13Jan14Apr14Jul14Oct14
Research & Development 385387376409360372360385365374
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK